15.11 USD
-0.2 (-1.31%)
ChartMill assigns a Buy % Consensus number of 82% to AUPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.03. This target is 6.08% above the current price.
AUPH was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AUPH.
In the previous month the buy percentage consensus was at a similar level.
AUPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-11-07 | Jefferies | Upgrade | Hold -> Buy |
| 2025-11-05 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-08-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-23 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | RBC Capital | Reiterate | Outperform |
| 2023-01-04 | RBC Capital | Maintains | Outperform |
| 2022-11-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-04 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-11-04 | RBC Capital | Maintains | Outperform |
| 2022-11-04 | SVB Leerink | Maintains | Outperform |
| 2022-08-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-08 | Oppenheimer | Maintains | Outperform |
| 2022-05-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-28 | RBC Capital | Maintains | Outperform |
| 2022-03-08 | SVB Leerink | Maintains | Outperform |
| 2022-03-01 | RBC Capital | Maintains | Outperform |
| 2022-02-23 | RBC Capital | Maintains | Outperform |
| 2021-12-10 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-11-04 | Oppenheimer | Maintains | Perform |
AURINIA PHARMACEUTICALS INC / AUPH FAQ
What do analysts expect the price target to be for AURINIA PHARMACEUTICALS INC (AUPH)?
13 analysts have analysed AUPH and the average price target is 16.03 USD. This implies a price increase of 6.08% is expected in the next year compared to the current price of 15.11.
Can you provide the consensus rating for AURINIA PHARMACEUTICALS INC stock?
The consensus rating for AURINIA PHARMACEUTICALS INC (AUPH) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover AURINIA PHARMACEUTICALS INC (AUPH) stock?
The number of analysts covering AURINIA PHARMACEUTICALS INC (AUPH) is 13.